The Share & Transparency

Share and ownership information

AdderaCare AB (publ) shares are traded on Nasdaq First North Growth Market. The share name is abbreviated to ADDERA and the ISIN code is SE0009160922. The first trading day was 1 December 2016.

List of shareholdings and shareholders as of 30-09-2020:

NameNumber of sharesShare of votes and capital
Bengt Olsson through company**2 881 16111,12 %
Hans Andersson through company and private******2 395 0329,25 %
Ampere i Malmö AB*2 346 7509,06 %
Jan Kvarnström****2 346 7509,06 %
Sannaskogen AB***2 331 8989,00 %
BAS Beheer BV*****1 388 9545.36 %
Other12 213 79047,15 %
Total25 904 335100,00 %

* Board member Per Nilsson owns together with related parties 100% of Ampere AB.
** Bengt Olsson owns 100% of Prosus Capital AB and 100 % of Prosus AB. Olsson was a board member of the parent company up to and including 28-09-2016. Olson is a board member of the parent company since 27-05-2020.
*** Bo Thorvinger owns 100% of Sannaskogen AB. Thorvinger was a board member of the parent company up to and including 28-09-2016.
**** Jan Kvarnström was a board member of the parent company up to and including 23-05-2019.
***** Bas Kamp owns 100 % of BAS Beheer BV, former owner of Huka BV.
****** Hans Andersson is a board member of AdderaCare AB since 23-05-2019 och chairman of the board since 27-05-2020.


For transactions carried out by persons in leading positions within AdderaCare AB, see:

Presentations and presentation materials

CEO Marianne Sernevi gives a presentation about AdderaCare at Erik Penser Bolagsdagen (November 2020).

CEO Marianne Sernevi is interviewed about AdderaCare (November 2020).

Previous CEO Michael Hermansson on the finances, listing and acquisition strategy going forward.

Previous CEO Michael Hermansson and previous Chairman of the Board Per Nilsson on AdderaCare.

Investment strategy & Financial goals

Investment strategy

We buy profitable, well-run companies that after the acquisition are allowed to continue operating as before and to keep their names, their culture and their management. Our well-thought-out and tried-and-tested process provides the acquisition procedure with structure and guarantees quality in the acquisitions that are made.

Our seven criteria for acquisition:

  • Positive cash flow
  • Profitable (operating profit EBITDA)
  • Majority of sales from own products/service
  • Most sales within the home care/accessibility aids sector
  • Company located in Nordic region
  • Seller prepared to sell the majority of the company
  • Not active within assistance

Financial goals

AdderaCare’s long-term goal is to create a corporate group that is financially profitable and demonstrates organic growth that is faster than that of the market.

AdderaCare’s goals:

  • During the build-up phase, to have sales growth of 30-50%
  • Profit margin above 10% over one economic cycle
  • Indebtedness must not be more than three times the operating profit (EBITDA)
  • Equity/assets ratio over 35%
  • Undertake a list change to Nasdaq Nordic Small Cap 2019-2020

Financial calendar


27 februari
Year-end Report

14 maj
Interim Report Q1

27 maj
Annual General Meeting

21 augusti
Half-yearly Report

19 november
Interim Report Q3


25 february
Year-end Report

5 may
Annual Report 2020

12 may
Interim Report Q2

26 may
Annual General Meeting

26 august
Half-yearly Report

11 november
Interim Report Q3

Articles of Association

AdderaCare’s Articles of Association are available to read in PDF format below (in Swedish):

AdderaCare bolagsordning pdf

Auditor & Certified Adviser (CA)



David Olow

Certified Adviser (CA)

Svensk Kapitalmarknadsgranskning AB
Phone: +46 11 32 30 732